Evidence map›Paper›PMID 27796617›Full record

ArticleInflammation2017

Heme-Exposed Pooled Therapeutic IgG Improves Endotoxemia Survival.

Iglika Djoumerska-Alexieva, Lubka T Roumenina, Tsvetanka Stefanova, Tchavdar Vassilev, Jordan D Dimitrov

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Iglika Djoumerska-AlexievaDepartment of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, 1113, Bulgaria. djoumer@microbio.bas.bg.ORCID http://orcid.org/0000-0002-4896-9908
Lubka T RoumeninaUMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Universités, UPMC Univ Paris 06, F-75006, Paris, France.
Tsvetanka StefanovaDepartment of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, 1113, Bulgaria.
Tchavdar VassilevDepartment of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, 1113, Bulgaria.
Jordan D DimitrovUMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Universités, UPMC Univ Paris 06, F-75006, Paris, France.
Bulgarian Academy of Sciences · BGDélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody repertoires of healthy humans and animals contain a fraction of antibodies able to acquire additional polyspecificity following exposure to several biologically relevant redox molecules (free heme, reactive oxygen species, ferrous ions, HOCl, etc.). The physiological role of these "hidden" polyspecific antibodies is poorly understood. Similar to inherently polyspecific antibodies, those with induced polyspecificicty may also have immunoregulatory properties. We have previously shown that a pooled human IgG preparation, modified by the exposure to ferrous ions, acquires the ability to significantly improve survival of animals with polymicrobial sepsis or aseptic systemic inflammation induced by bacterial lipopolysaccharide or zymosan administration. In the present study, we have analyzed the effects of administration of heme-exposed pooled human IgG in the same models of sepsis and aseptic systemic inflammation. The administration of a single dose of heme-exposed pooled IgG has resulted in a significant increase in the survival of mice with endotoxinemia, but not in those with polymicrobial sepsis and zymosan-induced severe generalized inflammation. Finally, we have provided evidence that the anti-inflammatory effect of heme-exposed IgG can be explained by scavenging of pro-inflammatory mediators.

Indexed as

AnimalsAntibody SpecificityAnti-Inflammatory AgentsEndotoxemiaHemeHumansImmunoglobulin GInflammationInflammation MediatorsLipopolysaccharidesMiceSepsisSurvival RateAnti-Inflammatory AgentsHemeImmunoglobulin GInflammation MediatorsLipopolysaccharidesantibody polyspecificityhemeIVIgpassive immunotherapysepsis

Identifiers

PMID27796617
OpenAlexW2541737925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.